TruBridge (TBRG) Stock Price, News & Analysis

Company Overview

TruBridge, Inc. is a technology solutions provider specializing in digital transformation and managed services for enterprise clients. The company focuses on helping organizations modernize and optimize their IT environments by leveraging cloud technologies, collaboration platforms, and security solutions. TruBridge’s core business activities include consulting, implementation, migration, training and ongoing support for Microsoft 365, Azure and related cloud services.

TruBridge offers a comprehensive suite of services designed to guide clients through every stage of their cloud adoption journey. Its offerings encompass license management and optimization, infrastructure design and deployment, change management and end-user training, as well as application development and integration. Through managed service agreements, TruBridge delivers continuous monitoring, maintenance and technical support to ensure seamless operations and rapid issue resolution.

The company serves a diverse range of industries, including government agencies, healthcare organizations, educational institutions and enterprises across North America and select international markets. By maintaining partnerships with leading technology vendors—most notably Microsoft—TruBridge stays at the forefront of product updates and best practices. Headquartered in the United States, the firm leverages a network of regional offices and remote teams to deliver tailored solutions that address both local regulatory requirements and global scalability needs.

Key Stats

• Today's Range: $25.95 to $25.97
• 50-Day Range: $14.00 to $25.96
• 52-Week Range: $13.88 to $26.51
• Volume: 122,085 shs
• Average Volume: 215,230 shs
• Market Capitalization: $389.48 million
• P/E Ratio: 129.78
• Dividend Yield: N/A
• Price Target: $23.95
• Consensus Rating: Hold

TruBridge Stock Analysis - MarketRank™

TruBridge scored higher than 55% of companies evaluated by MarketBeat, and ranked 495th out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

TruBridge has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 strong buy rating, no buy ratings, 7 hold ratings, and no sell ratings.

Downside Risk

TruBridge has a consensus price target of $23.95, representing about 7.7% downside from its current price of $25.96.

Amount of Analyst Coverage

TruBridge has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 41.50%

Earnings Growth

Earnings for TruBridge are expected to grow by 41.50% in the coming year, from $1.47 to $2.08 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of TruBridge is 129.78, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.30.

Price to Earnings Ratio vs. Sector

The P/E ratio of TruBridge is 129.78, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.14.

Price to Earnings Growth Ratio

TruBridge has a PEG Ratio of 2.23. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

TruBridge has a P/B Ratio of 2.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.72% of the float of TruBridge has been sold short.

Short Interest Ratio / Days to Cover

TruBridge has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in TruBridge has recently decreased by 5.15%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

TruBridge does not currently pay a dividend.

Dividend Growth

TruBridge does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.51

News Sentiment

TruBridge has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for TruBridge this week, compared to 3 articles on an average week.

Search Interest

Only 2 people have searched for TBRG on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 1.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, TruBridge insiders have not sold or bought any company stock.

Percentage Held by Insiders

10.70% of the stock of TruBridge is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

88.64% of the stock of TruBridge is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/08/2026
• Today: 6/01/2026
• Next Earnings (Estimated): 8/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:TBRG
• Previous Symbol: NASDAQ:TBRG
• CIK: 1169445
• Web: www.cpsi.com
• Phone: 251-639-8100
• Fax: 251-639-8214
• Employees: 3,500
• Year Founded: 2013

Price Target and Rating

• Average Price Target for TruBridge: $23.95
• High Price Target: $26.25
• Low Price Target: $18.00
• Potential Upside/Downside: -7.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.20
• Trailing P/E Ratio: 129.78
• Forward P/E Ratio: 17.66
• P/E Growth: 2.23
• Net Income: $4.21 million
• Net Margins: 0.92%
• Pretax Margin: -0.14%
• Return on Equity: 18.75%
• Return on Assets: 8.32%

Debt

• Debt-to-Equity Ratio: 0.90
• Current Ratio: 1.78
• Quick Ratio: 1.77

Sales & Book Value

• Annual Sales: $346.84 million
• Price / Sales: 1.12
• Cash Flow: $3.82 per share
• Price / Cash Flow: 6.79
• Book Value: $11.86 per share
• Price / Book: 2.19

Miscellaneous

• Outstanding Shares: 15,000,000
• Free Float: 13,394,000
• Market Cap: $389.33 million
• Optionable: Optionable
• Beta: 1.29